biotech.today

Details

  • ●Modalities: diagnostics, drug discovery
  • ●Therapeutic areas: oncology
  • ●Key targets:
  • ●Indications: Undisclosed
  • ●Funding: $180M

Partners & investors

  • BMS· Investor
  • MSD· Investor
  • Sanofi· Investor

Key considerations

  • ●AI tools in use: Owkin Platform, MOSAIC Dataset
  • ●$180M Series B (2021) led by Sanofi + BMS
  • ●Sanofi $180M strategic partnership
  • ●MSD partnership
Get live updates on Owkin’s hiring, filings, and partnerships. Follow in BT Pro →
Source: Company website, SEC / Companies House filings, press releases, Crunchbase · biotech.today analysis (Apr 2026)

Key people

Thomas Clozel

Co-Founder & CEO

federated-learningoncology-ai
Visit website →LinkedIn →